Hydroxybenzoic Acid Esters for HPV Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for HPV infections, condyloma acuminata, cervical erosion, and cervical cancer often come with side effects such as skin irritation and have limited effectiveness, necessitating the development of new antiviral agents that can safely and effectively target HPV-related diseases.
Innovation Solution
The use of hydroxybenzoic acid esters, specifically compounds like 2, 3, 4-trihydroxybenzoic acid ester and 3, 4, 5-trihydroxybenzoic acid ester, as active ingredients in medicaments and personal care products to prevent and treat HPV infections by effectively eliminating HPV 6/11 and 16/18 viruses, formulated into various pharmaceutical and personal care preparations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If podophyllotoxin is used to treat genital warts, then treatment time is shortened, but skin irritation and severe side effects occur
Solution Approach 1:
The patent changes the chemical structure parameter from podophyllotoxin to hydroxybenzoic acid esters (specifically gallate esters with different alkyl groups), maintaining antiviral efficacy while reducing toxic side effects through molecular modification
Solution Approach 2:
The patent employs multiple different hydroxybenzoic acid ester compounds (methyl gallate, ethyl gallate, propyl gallate, butyl gallate, etc.) that can be used in sequence or combination, replacing the single long-term treatment approach with alternative short-acting agents that reduce cumulative toxicity
2Reliability
If recombinant interferon α-2β gel is used to treat genital warts, then effectiveness is improved, but treatment complexity and cost increase
Solution Approach 1:
The patent uses simple chemical compounds (hydroxybenzoic acid esters) that are easier to manufacture and apply compared to complex biologic interferon preparations, reducing treatment complexity while maintaining effectiveness through direct topical application
3Reliability
If hydroxybenzoic acid esters are used as antiviral agents, then antiviral activity and stability are improved, but new compound development is required
Solution Approach 1:
The patent demonstrates that hydroxybenzoic acid esters serve multiple functions: they act as antiviral agents against HPV, maintain chemical stability, and can be incorporated into various pharmaceutical formulations (gels, creams, solutions), making them a universal platform for HPV treatment
Solution Approach 2:
The patent combines hydroxybenzoic acid esters with various pharmaceutical excipients and formulation components to create composite medicinal products that enhance stability and delivery while maintaining the core antiviral activity of the ester compounds
Data Source
AI summary
The use of hydroxybenzoic acid ester and analogues for the manufacture of a medicament for the prevention and treatment of viruses infection, especially human and animal HBV, HPV and HSVinfection is provided, wherein virus infection comprises HB, herpes simplex, condyloma acuminatum, vaginitis, cervicitis, and cervical erosion. Otherwise, the various kind of medicament and personal nursing product which are prepared by hydroxybenzoic acid ester and analogues and pharmaceutical adjuvant are provided.